- Research works
- 26 ▲ 10% vs 2013–17
- Citations
- 379 14.6 per fractional work
- Top-10% rate
- 25.3% record average 16.5%
- Open access
- 37% world 28%
Not ranked overall: Innovative Medicines Canada is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.0×. Every wedge is a field page.
Which keywords describe research at Innovative Medicines Canada?
By fractional works in all years, weighted toward what it does more of than the world: Pharmaceutical Industry, Vaccine, Drug Development Costs, Generic Drugs, Pathogenesis, Epidemiology, Academic Medicine and Medical Research.
- Polypharmacy
- Norovirus
- Inappropriate Medication Use
- Pathogenesis
- Drug Development Costs
- Pharmaceutical Industry
- Epidemiology
- Vaccine
- Generic Drugs
- Academic Medicine
- Medical Research
- Physician-Scientist
- Rotavirus
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 13 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 13 words, with their numbers
- Epidemiology2▲ 2.3×13 topics
- Pharmaceutical Industry2▲ 164×2 topics
- Vaccine2▲ 15×4 topics
- Drug Development Costs2▲ 235×1 topic
- Generic Drugs2▲ 235×1 topic
- Pathogenesis2▲ 10×6 topics
- Academic Medicine1▲ 65×2 topics
- Inappropriate Medication Use1▲ 96×1 topic
- Medical Research1▲ 136×1 topic
- Norovirus1▲ 66×1 topic
- Physician-Scientist1▲ 136×1 topic
- Polypharmacy1▲ 96×1 topic
- Rotavirus1▲ 66×1 topic
Which research topics does Innovative Medicines Canada publish most on?
By volume in 2022–2025: Control and Dynamics of Mobile Robots, Adaptive Control of Nonlinear Systems, Health Systems, Economic Evaluations, Quality of Life and Pharmaceutical Economics and Policy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Control and Dynamics of Mobile Robots Control and Systems Engineering 0 works
- 2 Adaptive Control of Nonlinear Systems Control and Systems Engineering 0 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 4 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 5 Kawasaki Disease and Coronary Complications Surgery 0 works
- 6 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 7 Vehicle Dynamics and Control Systems Automotive Engineering 0 works
- 8 Vasculitis and related conditions Pulmonary and Respiratory Medicine 0 works
- 9 Concrete Properties and Behavior Civil and Structural Engineering 0 works
- 10 Supercapacitor Materials and Fabrication Electronic, Optical and Magnetic Materials 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Innovative Medicines Canada's research output changed?
Output in 2018–2022 was 10% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Ottawa
- University of Ottawa
- Carleton University
- National Research Council Canada
- Agriculture and Agri-Food Canada
- Environment and Climate Change Canada
- Ottawa Hospital
- Atomic Energy (Canada)
- Fisheries and Oceans Canada
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.